Latest Survival motor neuron spinal muscular atrophy Stories
Spinal muscular atrophy (SMA) is an incurable, and progressive, disease caused by an inheritable defect in the gene SMN1.
A team of University of Missouri researchers have found that targeting a synthetic molecule to a specific gene could help the severity of the disease Spinal Muscular Atrophy (SMA) – the leading genetic cause of infantile death in the world.
These new awards encompass $745,000 for the basic research portion of the $3 Million in new research funding that FSMA announced earlier this year.
A new study from Cold Spring Harbor Laboratory (CSHL) reports surprising results that suggest that the devastating neuromuscular disease, spinal muscular atrophy (SMA), might not exclusively affect the motor neurons in the spinal cord as has long been thought.
Researchers in Ottawa report new hope for the treatment of infants born with serious genetic disorder.
Spinal muscular atrophy (SMA) is the most frequently inherited cause of infant mortality.
Failure in nerve-fiber navigation corrected in zebrafish model; suggests possibility of a drug treatment BOSTON, June 6, 2011 /PRNewswire-USNewswire/ -- Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA).
Children who suffer from the devastating disease Spinal Muscular Atrophy are set to benefit from a new breakthrough in therapy developments by researchers at the University of Sheffield.
Scientists from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have identified a promising new approach for developing drugs to treat Spinal muscular atrophy (SMA), the leading inherited cause of death in infants and toddlers.
- Large; stout; burly.